USING ARYNES

FIELD OF THE INVENTION

[0001] The invention relates to transition-metal-free N-arylation of tertiary amines using arynes. More particularly, present invention relates to coupling reaction between arynes generated in situ from 2-(trimethylsilyl)-aryl trifluoromethyl sulphonate of formula II and tertiary amines of formula III leading to transition- metal-free synthesis of tertiary arylamines of general formula I.

BACKGROUND AND PRIOR ART OF THE INVENTION

[0002] Arylamines are of considerable importance in a variety of industries. As such, the development of new and more general methods for their preparation is of significant interest. There is ample literature available on preparation of arylamines under catalytic conditions. The catalysts normally used in the synthesis are transition metal catalysts like Tin, Palladium and Copper.

[0003] Establishing an efficient, reliable method for the N-arylation of amines is currently a very active area of research in organic synthesis. Such aryl subunits are commonly found in a variety of biologically active and natural compounds, agrochemicals, HIV- protease inhibitors, and also compounds of interest in material science. Traditionally, the N-arylation of amines has been carried out under copper- mediated Ullmann-type conditions involving the coupling of amines with aryl halides. Although these copper-promoted reactions are useful, they usually require harsh reaction conditions and stoichiometric amounts of copper, and the yields are not very reproducible.

[0004] Article titled, "Palladium-Catalyzed Synthesis of Arylamines from Aryl Halides. Mechanistic Studies Lead to Coupling in the Absence of Tin Reagents" by Janis Louie and John F. Hartwig in Tetrahedron Letters, 1995, Vol. 36, No. 21, pp. 3609-3612 reports a reaction of aryl halides with secondary amines in the presence of silylamide base and tri-o-tolyphopshine palladium complexes to give arylamine products. This process provides a convenient method for performing this heterocross coupling reactions without the necessity for forming tin amides and disposing of tin halides. Further, it reports that this reaction follows from a mechanistic analysis of the coupling reaction with tin amides and occurs as a result of the cleavage of palladium aryl halide dimers with secondary amines.

[0005] Article titled, "A Simple Catalytic Method for the Conversion of Aryl Bromides to Arylamines" by Anil S. Guram, Roger A. Rennels, and Stephen L. Buchwald in Angew. Chem. Int. Ed. Engl. 1995, 34. Issue No. 12 reports a facile and general catalytic method for the conversion of aryl bromides to arylamines, which works well for inter- and intramolecular processes. Further, it reports that this method include the experimental simplicity with tin/boron-free conditions, and has a broad substrate scope. [0006] Article titled, "Nickel-catalyzed amination of aryl carbamates and sequential site-selective cross-couplings" by Tehetena Mesganaw, Amanda L. Silberstein, Stephen D. Ramgren, Noah F. Fine Nathel, Xin Hong, Peng Liu and Neil K. Garg in Chem. Sci., 201 1, 2, 1766 reports the amination of aryl carbamates using nickel- catalysis. It also demonstrates that aryl carbamates are outstanding precursors for the synthesis of polysubstituted aryl amines using sequential carbamate functionalization/site-selective coupling processes.

[0007] Recent developments in transition-metal-free carbon-carbon and carbon- heteroatom bond-forming reactions utilizing a versatile class of reactive ^* intermediates, viz., arynes, holds the potential for numerous applications in organic synthesis. Consequently, arynes have been employed for the construction of multisubstituted arenes with structural diversity and complexity. The versatile transition-metal-free applications of arynes include cycloaddition reactions, insertion reactions and multicomponent reactions. In addition, arynes have found applications in natural product synthesis.

[0008] Article titled, "Transition-metal-free a-Arylation of β-keto amides via an interrupted insertion reaction of arynes" by Kishor Mohanan, Yoann Coquerel, and Jean Rodriguez reported in Org. Lett., 2012, 14 (17), pp 4686^1689 reports direct a- arylation reactions of secondary β-keto amides with arynes, generated by fluoride- induced elimination of ortho-si lylaryltriflates. The transformation proceeds via an interrupted insertion reaction of arynes and leads to densely functionalized aromatic compounds exhibiting a chiral 'all carbon' quaternary center under transition-metal- free conditions.

[0009] There are several reports on transition-metal-catalyzed synthesis of tertiary aryl amine derivatives, but the transition-metal free syntheses of tertiary arylamine derivatives are relatively rare. For example, a facile synthesis transition-metal-free procedure for the N-arylation of amines by Zhijian Liu et al reported in J.. Org. Chem. 2006 April 14;71(8): 3198-3209 reports a reaction of amine with variety of o- silylaryl inflates in the presence of CsF in acetonitrile to yield the N-arylated amines. However, in the inventor's hands, synthesis of aryl amines were achieved using primary and secondary amines only, but using tert-amines, the arylation was not feasible. Despite these significant recent improvements, there still remains a need in the art to prepare tertiary arylamine derivatives in good yields utilizing the cheaper sources in cost effective manner.

OBJECTIVE OF THE INVENTION

[0010] The main object of the present invention is to provide a transition-metal-free process for N-arylation of tertiary amines using arynes generated in situ.

[0011] Another object of the present invention is to provide a coupling reaction between arynes generated in situ and tertiary amines derivatives leading to transition-metal-free synthesis of tertiary arylamines. SUMMARY OF THE INVENTION

[0012] Accordingly, present invention provides a transition metal-free synthesis of tertiary arylamines compounds of general formula (I)

General formula I

wherein

Rl= ethyl, methyl or;

R2= H, alkyl (C1-C5), aryl (phenyl, C6-C8), halogen (F, CI, Br, I), esters (C2- C4), CHO, CN, OH, CH=CH-COOEt, CH=CH-C6H4N02, OCH3, OPh,

R3=H, CH ₃ , halogen (F, CI, Br, I),

R4=H or D;

or R2+R3=-0-CH2-0-, -CH=CH-CH=CH-; -C(S02C1)=CH-CH=CH-;

comprising the steps of:

i. mixing 2-trimethylsilylaryl trifluoromethyl sulphonate of formula (II) and tertiary amine compounds of formula (III) in the ratio ranging between 2: 1 to 1 :2 in presence of 18-crown-6, KF and solvent (THF)

Formula II Formula III

wherein R',R ² and R ³ is as defined above.

[0013] In an embodiment of the present invention, the 2-trimethylsilylaryl trifiuoromethyl sulphonate are selected from the group consisting of 3,6-dimethyl-2- (trimethylsilyl)phenyl trifluoromethanesulfonate, 4,5-dimethyl-2- ·

(trimethylsilyl)phenyl trifluoromethanesulfonate, 6-

(trimethylsilyl)benzo[d][l,3]dioxol-5-yl trifluoromethanesulfonate, 4,5-difluoro-2- (trimethylsilyl)phenyl tri-fluoromethanesulfonate, 3,6-dimethyl-2- (trimethylsilyl)phenyl trifluoromethanesulfonate, 2-methoxy-6-

(trimethylsilyl)phenyl trifluoromethanesulfonate, 2-(trimethylsilyl)-naphthalen-l -yl trifluoromethanesulfonate, 4-methyl-2-(trimethylsilyl)-phenyl trifluoromethanesulfonate.

[0014] In another embodiment of the present invention, the tertiary amine compounds are selected from the group consisting of N.N-diethylaniline , N-methyl- N-phenylaniline, NN-dimethylaniline, N,N,4-trimethylaniline, 3- (dimethylamino)phenol, 4-bromo-N,N-dimethylaniline, 4-iodo-N,N-dimethyl aniline, 4-(dimethylamino) benzonitrile, ethyl 4-(dimethylamino)benzoate, 4- (dimethylamino) benzaldehyde, N,N,3-trimethylaniline, 3-bromo-N,N- dimethylaniline, methyl 2-(dimethylamino)benzoate, N,N,3,5-tetramethyl aniline, diethyl (4-(dimethylamino)benzyl)phosphonate, (E)-N,N-dimethyl-4-(2-(thiophen-2- yl)vinyl)aniline, N,N-dimethyl-4-(phenylethynyl)aniline, N,N-dimethyl naphthalen- 1 -amine, 5-(dimethyl-amino) naphthalene- 1-sulfonyl chloride, 4,4'- (phenylmethylene)bis(N,N-dimethylaniline), ethyl (E)-3-(4- · (dimethylamino)phenyl)acrylate, (E)-N,N-dimethyl-4-(4-nitrostyryl)-aniline, 5-(4- (dimethylamino)phenyl)thiophene-2-carbaldehyde, 3-(dimethylamino)phenol, 1 ,2,3,4-tetrahydroisoquinoline.

[0015] In yet another embodiment, present invention further comprises addition of 1.0 equiv ammonium bicarbonate (NH ₄ HCO ₃ ) to increase the yield of tertiary arylamines.

[0016] In yet another embodiment of the present invention, the reaction is carried out at a temperature in the range of 58 to 62°C for period in the range of 1 1 to 12 hours.

[0017] In yet another embodiment of the present invention, the coupling reaction is carried out under argon atmosphere.

BRIEF DESCRIPTION OF THE DRAWINGS [0018] Scheme 1 represents transition metal free process for the synthesis of tertiary arylamine of general formula I.

[0019] Scheme 2 represents synthesis of N-methyl-N-phenylaniline as in example 1.

[0020] Scheme 3 represents synthesis of N-methyl-N-phenylaniline as in example 2.

[0021] Scheme 4 represents synthesis of N,N-dimethyl-N-(p- tolyl)benzo[d][l,3]dioxol-4-aminium salt as in example 3.

DETAILED DESCRIPTION OF INVENTION

[0022] The present invention provides a transition metal free method for the synthesis of tertiary arylamine of general formula I by the reaction of arynes generated by 2-trimethylsilylaryl trifluoromethyl sulphonate of formula II with tertiary amine of formula III in excellent yields. One preferred tertiary amine is N,N- dimethyl aniline.

[0023] Accordingly, present invention provides a transition metal-free process for the synthesis of tertiar arylamines compounds of general formula (I)

General Formula I

wherein

R2= H, alkyl (C1-C5), aryl (phenyl, C6-C8), halogen (F, CI, Br, I), esters (C2- C

R3=H, CH ₃ , halogen (F, CI, Br, I),

R4=H or D; or R2+R3=-0-CH2-0-, -CH=CH-CH=CH-; -C(S02C1)=CH-CH=CH-;

comprising the steps of:

i. mixing aryne precursor 2-trimethylsilylaryl trifluoromethyl sulphonate of formula (II) and tertiary amines derivatives of formula (III) in presence of 18-crown-6, KF and solvent (THF) and optionally in the presence of a base at a temperature in the range of 58 to 62 °C preferably 60°C under inert atmosphere for a period of 10-15 hrs referably 12 hrs.

Formula II Formula III

wherein R*,R ² and R ³ is as defined above;

[0024] The present invention provides a transition-metal-free synthesis of tertiary arylamines of general formula I further comprising of addition of ammonium bicarbonate ( H ₄ HCO3) to increase the yield.

[0025] The aryne precursors 2-trimethylsilylaryl trifluoromethyl sulphonate of formula (II) are selected from the group comprising 3,6-dimethyl-2- (trimethylsilyl)phenyl trifluoromethanesulfonate, 4,5-dimethyl-2-

(trimethylsilyl)phenyl trifluoromethanesulfonate, 6-

(trimethylsilyl)benzo[d][l,3]dioxol-5-yl trifluoromethanesulfonate, 4,5-difluoro-2- (trimethylsilyl)phenyl tri-fluoromethanesulfonate, 3 ,6-dimethyl-2- (trimethylsilyl)phenyl trifluoromethanesulfonate, 2-methoxy-6-

(trimethylsilyl)phenyl trifluoromethanesulfonate, 2-(trimethylsilyl)-naphthalen- 1 -yl trifluoromethanesulfonate, 4-methyl-2-(trimethylsilyl)-phenyl trifluoromethanesulfonate.

[0026] The tertiary amines of Formula III are selected from the group comprising · of N,N-diethylaniline, N,N-dimethylaniline, N,N,4-trimethylaniline, 3- (dimethylamino)phenol, 4-bromo-N,N-dimethylaniline, 4-iodo-N,N-dimethyl aniline, 4-(dimethylamino) benzonitrile, ethyl 4-(dimethylamino)benzoate, 4- (dimethylamino) benzaldehyde, N,N,3-trimethylaniline, 3-bromo-N,N- dimethylaniline, methyl 2-(dimethylamino)benzoate, N,N,3,5-tetramethyl aniline, diethyl (4-(dimethylamino)benzyl)phosphonate, (E)-N,N-dimethyl-4-(2-(thiophen-2- yl)vinyl)aniline, N,N-dimethyl-4-(phenylethynyl)aniline, N,N-dimethyl naphthalen- 1 -amine, 5-(dimethyl-amino) naphthalene- 1-sulfonyl chloride, 4,4'- (phenylmethylene)bis(N,N-dimethylaniline), ethyl (E)-3-(4-

(dimethylamino)phenyl)acrylate, (E)-N,N-dimethyl-4-(4-nitrostyryl)-aniline, 5-(4- (dimethylamino)phenyl)thiophene-2-carbaldehyde, 3-(dimethylamino)phenol, 1 ,2,3,4-tetrahydroisoquinoline.

[0027] The invention further demonstrates the optimization of reaction conditions ' and molar ratios of the reactants along with the yields and tabulated below in table 1 5 and table 2.

Table 1

Table 2

Reaction temperature 40 °C instead of 60 °C with (NH ₄ )HCO ₃ 1.0 88 equiv as a additive

Reaction time 6 h instead of 12 h with (NH ₄ )HC0 ₃ 1.0 equiv as a 78 additive

a Standard conditions: 1 (0.25 mmol), 2 (0.30 mmol), KF (2.4 equiv), 18-crown-6 (2.4 equiv), THF (1.0 mL), 60 °C and 12 h.

b The yields were determined by Ή NMR analysis of crude products using CH ₂ Br ₂ as the internal standard.

c Isolated yield at 0.25 mmol scale.

d Isolated yield at 0.50 mmol scale in parentheses.

[0028] As is evident from the above table, use of base facilitates the reaction and ^' thus yield of the product (refer entry 1 and 2). It is further observed that the yield is higher at higher temperature when the other conditions are same (refer entry 2 and 3) and the appropriate moiar ratio of compounds 1 and 2 observed to be in the range of 1 : 2 to 2: 1 and product yield may vary in the range of 60-96%.

EXAMPLES

The following examples are given by way of illustration and therefore should not be construed to limit the scope of the invention.

Example 1

[0029] Synthesis of N-methyk/V-phenylaniline (Scheme 2) To a flame-dried screw-capped tube equipped with a magnetic stir bar were added 18-crown-6 (0.317 g, 1.2 mmol), KF (0.070 g, 1.2 mmol) and NH ₄ HC0 ₃ (0.040 g, 0.50, mmol).Then the screw-

capped tube was evacuated and backfilled with argon. The mixture was dissolved in THF (2.0 mL) under argon atmosphere and then to the stirring solution were added the N, N-dimethylaniline 1 (0.061 g, 65 / L, 0.50 mmol) and 2-(trimethylsilyl) phenyltrifluoro-methanesulfonate 2 (0.179 g, 146 ^L, 0.60 ^* mmol) at room temperature (27°C). Then the screw-capped tube kept in a preheated oil bath at 60 °C for 12 h. The reaction mixture cooled and the residue on column chromatography afforded N-methyl-N-phenylaniline 3 as a colourless oil (0.087 g,

95%).

R Pet. ether DCM = 90/10): 0.66; Ή NMR (400 MHz, CDC1 ₃ ) δ 7.28 (t, J= 7.6 Hz, 4H), 7.03 (d, J = 8.2 Hz, 4H), 6.96 (t, J = 7.3 Hz, 2H), 3.32 (s, 3H). ¹³ C NMR (100 MHz, CDC1 ₃ ): δ 149.18, 129.33, 121.39, 120.58, 40.38. HRMS (ESI) calculated [M+H] ⁺ for C, ₃ Hi ₄ N: 184.1121, found: 184.1 1 18. FTIR (cm ^"1 ): 3036, 2929, 2879, 1591, 1496, 1342, 1271, 1253, 1 186, 1 156, 1 131, 1092, 1074, 1029, _, 864, 750, 693. Example 2

[0030] Synthesis of N-methyl-N-phenylaniline in the absence of NH ₄ HCO ₃ (Scheme 3) To a flame-dried screw-capped tube equipped with a magnetic stir bar were added N, N-dimethylaniline 1 (0.030 g, 32.0 L, 0.25 mmol) and 2-(trimethylsilyl) phenyltrifluoromethanesulfonate 2

(0.090 g, 73 pL, 0.30 mmol). The mixture was dissolved in THF (1.0 mL) under argon atmosphere and then to the stirring solution was added the tetrabutyl ammonium fluoride (TBAF) (0.60 mL, 0.60 mmol) at room temperature (25°C). Then the tube was kept in a preheated oil bath at 60 °C for 12 h. Usual processing of the reaction mixture followed by column chromatography of a crude reaction mixture afforded N-methyl-N-phenylaniline 3 as a colourless oil (0.033 g, 73%).

Example 3

[0031] Synthesis of N,N-dimethyl-N-(p-tolyl)benzo[d][l,3]dioxol-4-aniinium salt (intermediate in this reaction) (Scheme 4) To a flame-dried screw-capped tube equipped with a magnetic stir bar was added dry CsF (0.095 g, 0.60 mmol) and then CH ₃ CN under argon atmosphere (1.0 mL). To the stirring solution N, N, 4-trimethylaniline 4 (0.034 g, 37 ί, 0.25 mmol) and 6-(trimethylsilyl) benzo[d][l, 3]dioxol-5-yl trifluoromethanesulfonate 5 (0.102 g, 0.3 mmol) were added at room temperature (27°C). Then tube was kept in a preheated oil bath at 60 °C for 12 h. The reaction mixture cooled and the residue was purified by column chromatography to afford N,N-dimethyl-N-(p-tolyl)benzo[d][l,3]dioxol-4-aminium salt 6 as a white solid. (0.100 g, 95%).

Ή NMR (400 MHz, CDC1 ₃ ) δ 7.40 (d, J = 8.6 Hz, 2H), 7.29 (d, J = 8.6 Hz, 2H), 7.18 (dd, J, = 8.8 Hz,J ₂ = 2.6 Hz, 1H), 6.84 (d, J = 8.8 Hz, 1H), 6.75 (d, J = 2.6 Hz, 1H), 6.01 (s, 2H), 3.95 (s, 6H), 2.35 (s, 3H). ¹³ C NMR (100 MHz, CDC1 ₃ ) δ 149.30, 149.14, 146.39, 142.56, 141.16, 131.18, 120.84, 114.84, 108.41, 103.02, 102.89, 58.99, 20.90. ¹⁹ F NMR (376 MHz, CDC1 ₃ ) δ -78.41.HRMS (ESI) calculated [Mf for C ₎₆ H ₁₈ 0 ₂ N: 256.1332, found: 256.1334. FTIR (cm ¹ ): 3504, 31 14, 3059, 3016, 2919, 1615, 1508, 1488, 1383, 1263, 1226, 1159, 1125, 1112, 1031, 971, 927, 898, 819, 756, 639.

Example 4

[0032] Synthesis of JV, 4-DimethyI-TV-phenylaniline

(2.0 mL) at 60 °C for 12 h followed by column chromatography (Pet. ether/DCM = 98/02) afforded N,4-dimethyl-N-phenylaniline as a colorless oil (0.091 g, 92%). tf/Pet. ether/DCM = 90/10): 0.64; Ή NMR (400 MHz, CDC1 ₃ ) δ 7.29-7.25 (m, 2H), 7.16 (d, J = 8.1 Hz, 2H), 7.04 (d, J = 8.4 Hz, 2H), 6.98-6.95 (m, 2H), 6.91 (t, J = 7.3 Hz, 1H), 3.33 (s, 3H), 2.37 (s, 3H). ¹³ C NMR (100 MHz, CDC1 ₃ ) δ 149.50, 146.73, 132.19, 130.05, 129.15, 122.69, 1 19.93, 118.33, 40.46, 20.88.HRMS (ESI) calculated [M+H] ⁺ for C ₁₄ Hi ₆ N: 198.1277, found: 198.1275. FTIR (cm ¹ ): 3059, 3027, 2923, 2870, 1597, 1572, 1512, 1497, 1342, 1296, 1268, 1254, 1 187, 1 131, 1089, 1067, 868, 822, 751, 696.

Example 5

[0033] Synthesis of 4-Bromo-N-methyk/V-phenylaniline

(2.0 mL) at 60 °C for 12 h followed by column chromatography (Pet. ether DCM = 98/02) afforded 4-bromo-N-methyl-N-phenylaniline as a white solid (0.1 12 g, 85%).

R Pet. ether/DCM = 90/10): 0.62; Ή NMR (400 MHz, CDC1 ₃ ) δ 7.34-7.29 (m, 4H), 7.07-7.01 (m, 3H), 6.84 (d, J = 8.8 Hz, 2H), 3.29 (s, 3H). ¹³ C NMR (100 MHz, CDC1 ₃ ) δ 148.67, 148.26, 132.07, 129.55, 122.71, 122.09, 120.71, 1 12.80, 40.42.HRMS (ESI) calculated [M+H] ⁺ for C ₁₃ H, ₃ NBr: 262.0226, found: 262.0256. FTIR (cm- ¹ ): 3062, 3037, 2926, 2882, 2815, 1583, 1489, 1454, 1343, 1254, 1 185, 1 133, 1 1 19, 1075, 866, 815, 754, 734, 696 (C-Br).

Example 6

[0034] Synthesis of 4-Iodo-N-methyl-N-phenylaniline Following the general procedure, treatment of 4-iodo-N.N- dimethyl aniline (0.124 g, 0.50 mmol) with 2- (trimethylsilyl)phenyltrifluoromethanesulfonate (0.179 g, 146 μΐ, , 0.60 mmol) in the presence of KF (0.070 g, 1.20 mmol) , 18-crown-6 (0.317 g, 1.20 mmol) and (NH ₄ )HC0 ₃ (0.040 g, 0.50 mmol) in THF (2.0 mL) at 60 °C for 12 h followed by column chromatography (Pet.ether/ DCM = 98/02) afforded 4-iodo-N-methyl-N-phenylanilineas a white solid (0.131 g, 85%). R/Pet. ether/DCM = 90/10): 0.64; Ή NMR (400 MHz, CDC1 ₃ ) δ 7.50 (d, J = 8.8 Hz, 2H), 7.32 (t, J = 8.2 Hz, 2H), 7.10-7.04 (m, 3H), 6.72 (d, J = 8.8 Hz, 2H), 3.29 (s, 3H). ¹³ C NMR (100 MHz, CDC1 ₃ ): δ 148.85, 148.46, 137.95, 129.60, 123.13, 122.68, 120.66, 82.20, 40.34. HRMS (ESI) calculated [M+H] ⁺ for Ci ₃ H, ₃ IN: 310.0092, found: 310.0100. FTIR (cm ^"1 ): 3025, 2923, 2815, 1577, 1481, 1333, 1237, 1118, 1056, 805, 746, 687.

Example 7

[0035] Synthesis of4-(Methyl (phenyl) amino) benzonit ile g the general procedure, treatment of 4- lamino) benzonitrile (0.073 g, 0.50 mmol) with 2- lsilyl)phenyl trifluoromethanesulfonate (0.179 g, 0.60 mmol) in the presence of KF (0.070 g, 1.20 mmol), 18-crown-6 (0.317 g, 1.20 mmol) and (NH4)HC0 ₃ (0.040 g, 0.50 mmol) in THF (2.0 mL) at 60 °C for 12 h followed by column chromatography (Pet. ether/EtOAc = 98/01) afforded 4-(methyl(phenyl)amino) benzonitrile as a colorless oil (0.062 g, 60%).

R/Pet. ether/EtOAc = 95/05): 0.60;Ή NMR (400 MHz, CDC1 ₃ ) δ 7.46-7.42 (m, 4H), 7.30-7.21 (m,3H), 6.74 (d, J = 8.9 Hz, 2H), 3.36 (s, 3H). ¹³ C NMR (100 MHz, CDC1 ₃ ) δ 152.04, 146.87, 133.35, 130.17, 126.56, 126.31, 120.48, 1 13.91, 99.40, 40.26.HRMS (ESI) calculated [M+H] ⁺ for C _M H, ₃ N ₂ : 209.1073, found: 209.1077. FTIR (cm ^"1 ): 3061, 3039, 2946, 2886, 2215 (cyano group), 1609, 1591, 1513, 1494, 1355, 1257, 1176, 1142, 1119, 869, 823, 773, 701.

Example 8

[0036] Synthesis of Ethyl 4-(methyl (phenyl) amino) benzoate Following the general procedure, treatment of ethyl 4- (dimethylamino)benzoate (0.097g, 0.50 mmol) with 2- (trimethylsilyl)phenyl trifluoromethanesulfonate (0.179 g, 146 μί, 0.60 mmol) in the presence of KF (0.070 g, 1.20 mmol) ,18-crown-6 (0.317 g, 1.20 mmol) and (Ν¾)Ηαθ ₃ (0.040 g, 0.50 mmol) in THF (2.0 mL) at 60 °C for 12 h followed by column chromatography (Pet.ether/EtOAc = 99/01) afforded Ethyl 4-(methyl(phenyl) amino) benzoate as a colorless oil (0.110 g, 86%).

R/Pet. ether/EtOAc = 95/05): 0.63;Ή NMR (400 MHz, CDC1 ₃ ) δ 7.88 (d, J = 8.9 Hz, 2H), 7.39 (t, J = 7.8 Hz, 2H), 7.22-7.18 (m, 3H), 6.77 (d, J = 8.9 Hz, 2H), 4.33 (q, J = 7.1 Hz, 2H), 3.36 (s, 3H), 1.36 (t, J = 7.1 Hz, 3H). ¹³ C NMR (100 MHz, CDC1 ₃ ) δ 166.90, 152.57, 147.66, 131.06, 129.89, 125.89, 125.36, 119.67, 113.98, , 60.41, 40.33, 14.57.HRMS (ESI) calculated [M+H] ⁺ for Ci ₆ Hi ₈ 0 ₂ N: 256.1332, found: 256.1353. FTIR (cm ¹ ): 3061, 3038, 2980, 2820, 1705 (ester), 1609, 1591, 1567, 1515, 1495, 1351, 1314, 1276, 1 181, 1 107, 870, 840, 768, 730, 698.

Example 9

[0037] Synthesis of 4-(Methyl (phenyl) amino) benzaldehyde

5

Following the general procedure, treatment of 4- ( ^dimeth >' ^lanimo ) benzaldehyde (0.075 g, 0.50 mmol) with 2-(trimethylsilyl)phenyl trifluoromethanesulfonate (0.179 g,

146 μΐ. , 0.60 mmol) in the presence of KF (0.070 g, 1.20 mmol) , 18-crown-6 (0.317 g, 1.20 mmol) and (NH ₄ )HC0 ₃ (0.040 g, 0.50 mmol) in THF (2.0 mL) at 60 °C for 12 h followed by column chromatography (Pet. ether/EtOAc = 95/05) afforded 4-(methyl(phenyl)amino)benzaldehydeas a yellow solid (0.032 g, 30%).

R/Pet. ether EtOAc = 90/10): 0.37;Ή NMR (400 MHz, CDC1 ₃ ) δ 9.76 (s, 1H), 7.69 (d, J= 8.9 Hz, 2H ), 7.44 (t, J = 7.8 Hz, 2H), 7.28-7.27 (m, 1H), 7.23 (d, J= 7.8 Hz, 2H), 6.78 (d, J = 8.9 Hz, 2H ), 3.39 (s, 3H). ^,3 C NMR (100 MHz, CDC1 ₃ ) δ 190.52, 153.88, 147.00, 131.78, 130.13, 126.79, 126.67, 126.33, 1 13.51, 40.43.HRMS (ESI) calculated [M+H] ⁺ for Ci ₄ H ₎₄ ON: 212.1070, found: 212.1074. FTIR (cm ^"1 ): 3061, 3037, 2918, 2818, 2732, 1683, 1604, 1587, 1560, 1516, 1494, 1355, 1310, 1257, 1232, 1 167, 1 135, 1 1 19, 1 135, 1 1 19, 1069, 1025, 872, 822, 769, 715, 699.

Example 10

[0038] Synthesis of N, 3-Dimethy V-phenylaniline

^Me Following the general procedure, treatment of N,N,3-

^Μβ γ ^" ^ ^{Ν <} Υ2^ trimethylaniline (0.068 g, 72 μί, 0.50 mmol) with 2- \^ \^ (trimethylsilyl)phenyl trifluoromethanesulfonate (0.179 g, 146 μΐ. , 0.60 mmol) in the presence of KF (0.070 g, 1.20 mmol) , 18-crown-6 (0.317 g, 1.20 mmol) and (NH ₄ )HC0 ₃ (0.040 g, 0.50 mmol) in THF (2.0 mL) at 60 °C for 12 h followed by column chromatography (Pet. ether/DCM = 98/02) afforded N,3- dimethyl-N-phenylaniline as a colorless oil (0.095 g, 96%).

/Pet. ether/DCM = 90/10): 0.64;Ή NMR (400 MHz, CDC1 ₃ ) δ 7.30 (t, J = 7.9 Hz, 2H), 7.20 (t, J = 7.7 Hz, 1H), 7.04 (d, J = 7.8 Hz, 2H), 6.97 (t, J = 7.3 Hz, 1H), 6.89-6.87 (m, 2H), 6.83 (d, J = 7.3 Hz, 1H ), 3.34 (s, 3H), 2.34 (s, 3H). ¹³ C NMR (100 MHz, CDC1 ₃ ) δ 149.27, 149.15, 139.14, 129.26, 129.16, 122.51, 121.60, 121.07, 120.24, 1 18.06, 40.40, 21.69.HRMS (ESI) calculated [M+H] ⁺ for Ci ₄ Hi ₆ N: 198.1277, found: 198.1277. FTIR (cm ¹ ): 3037, 2920, 281 1, 1594, 1583, 1495, 1456, 1344, 1262, 1 191, 1172, 1127, 1094, 1071, 1029, 993, 922, 806, 751, 693. Example 11

[0039] Synthesis of 3-Bromo-iV-methyl-N-phenylaniline

Following the general procedure, treatment of 3-bromo-N,N- dimethylaniline (0.100 g, 0.50 mmol) with 2- (trimethylsilyl)phenyl trifluoromethanesulfonate(0.179 g, 146 μΕ , 0.60 mmol) in the presence of KF (0.070 g, 1.20 mmol) , 18-crown-6 (0.317 g, 1.20 mmol) and (NH ₄ )HC0 ₃ (0.040 g, 0.50 mmol) in THF (2.0 mL) at 60 °C for 12 h followed by column chromatography (Pet. ether/DCM = 98/02) afforded 3-bromo- N-methyl-N-phenylaniline as a colorless oil (0.123 g, 94%).

i?/Pet. ether/DCM = 90/10): 0.63;Ή NMR (400 MHz, CDC1 ₃ ) δ 7.37-7.33 (m, 2H), 7.13-7.06 (m, 5H), 6.99 (d, J = 7.4 Hz, 1H), 6.84 (d, J = 8.2 Hz, 1H), 3.31 (s, 3H). ¹³ C NMR (100 MHz, CDC1 ₃ ) δ 150.54, 148.34, 130.35, 129.68, 123.60, 123.39, 123.15, 122.62, 120.54, 116.47, 40.39.HRMS (ESI) calculated [M+H] ⁺ for Ci ₃ Hi ₃ NBr: 262.0226, found: 262.0229. FTIR (cm ¹ ): 3402, 3062, 3037, 2927, 2814, 1586, 1560, 1495, 1481, 1343, 1247, 1133, 1101, 1081, 1070, 984, 887, 835, 760, 699 (C-Br).

Example 12

[0040] Synthesis of Methyl 2-(methyl (phenyl) amino) benzoate

20

Following the general procedure, treatment of methyl 2- (dimethylamino)benzoate (0.090 g, 0.50 mmol) with 2- (trimethylsilyl)phenyl trifluoromethanesulfonate (0.179 g,

146 μΐ, , 0.60 mmol) in the presence of KF (0.070 g, 1.20 mmol) ,18-crown-6 (0.317 g, 1.20 mmol) and (NH ₄ )HC0 ₃ (0.040 g, 0.50 mmol) in THF (2.0 mL) at 60 °C for 12 h followed by column chromatography (Pet. ether/EtOAc = 99/01) afforded methyl 2-(methyl(phenyl)amino)benzoate as a yellow oil (0.079 g, 65%).

R/Pet. ether/EtOAc = 95/05): 0.63;1H NMR (400 MHz, CDC1 ₃ ) δ 7.81 (d, J = 7.7 Hz, 1H), 7.54 (t, J = 7.9 Hz, 1H ), 7.30-7.27 (m, 2H), 7.18-7.15 (m, 2H), 6.75 (t, J = 7.2 Hz, 1H), 6.65 (d, J = 7.9 Hz, 2H ), 3.60 (s, 3H), 3.29 (s, 3H). ¹³ C NMR (100 MHz, CDC1 ₃ ) δ 167.62, 149.38, 148.25, 133.36, 131.54, 129.44, 129.15, 129.01, 125.35, 1 _. 18.11, 114.40, 52.15, 40.47.HRMS (ESI) calculated [M+H] ⁺ for Ci ₅ Hi ₆ 0 ₂ N: 242.1176, found: 242.1176. FTIR (cm ^"1 ): 3384, 3062, 3036, 2997, 2949, 2884, 2814, 1732 (ester), 1594, 1500, 1454, 1433, 1349, 1293, 1247, 1 189, 1127, 1097, 1080, 1068, 991, 965, 871, 772, 749, 716, 693. Example 13

[0041] Synthesis of N, 3, 5-trimethyI-N-phenylaniline

Following the general procedure, treatment of N,N,3,5 tetramethyl aniline (0.075 g, 82 μL, 0.50 mmol) with 2

(trimethylsilyl)phenyl trifluoromethanesulfonate (0.179 g, 146 μΐ,, 0.60 mmol) in the presence of KF (0.070 g, 1.20

mmol) ,18-crown-6 (0.317 g, 1.20 mmol) and (NH ₄ )HC0 ₃ (0.040 g, 0.50 mmol) in THF (2.0 mL) at 60 °C for 12 h followed by column chromatography (Pet. ether/ DCM = 98/02) afforded N,3,5-trimethyl-N- phenylaniline as a colorless oil (0.086 g, 81%).

R/Pet. ether/DCM = 90/10): 0.59; Ή NMR (400 MHz, CDC1 ₃ ) δ 7.32-7.28 (m, 2H), 7.03 (d, 7 = 7.7 Hz, 2H), 6.96 (t, J = 7.4 Hz, 1H), 6.72 (s, 2H), 6.68 (s, 1H), 3.32 (s, 3H), 2.30 (s, 6H). ¹³ C NMR (100 MHz, CDC1 ₃ ): δ 149.33, 149.12, 138.97, 129.22, 123.72, 120.83, 119.98, 119.01, 40.46, 21.57. HRMS (ESI) calculated [M+H] ⁺ for Ci ₅ H, ₈ N: 212.1439, found: 212.1442. FTIR (cm ^-1 ): 3035, 2917, 2869, 2811, 1591, 1497, 1379, 1349, 1289, 1259, 1205, 1130, 1097, 1030, 1005, 992, 934, 847, 824, 785, 751, 693.

Example 14

[0042] Synthesis of Diethyl (4-(methyl (phenyl) amino) benzyl) phosphonate

Following the general procedure, treatment of diethyl (4-(dimethylamino)benzyl)phosphonate(0.135 g, 0.50 mmol) with 2-(trimethylsilyl)phenyl trifluoromethanesulfonate (0.179 g, 146μί , 0.60 mmol) in the presence of KF (0.070 g, 1.20 mmol) , 18-crown-6 (0.317 g, 1.20 mmol) and (NH ₄ )HC0 ₃ (0.040 g, 0.50 mmol) in THF (2.0 mL) at 60 °C for 12 h followed by column chromatography (Pet. ether/EtOAc = 50/50) afforded diethyl (4-(methyl(phenyl)amino)benzyl)phosphonate as a yellow oil (0.144 g, 87%).

R/Pet. ether/EtOAc = 40/60): 0.41; Ή NMR (400 MHz, CDC1 ₃ ) δ 7.29 (t, J = 8.1 Hz, 2H), 7.22 (dd, J, = 8.5 Hz, J ₂ = 2.4 Hz, 2H), 7.03 (d, J= 7.8 Hz, 2H), 6.99-6.96 (m, 3H), 4.09-4.02 (m, 4H ), 3.32 (s, 3H), 3.12(d, J = 21.3 Hz, 2H), 1.29 (t, J = 7.1 Hz, 6H ). ¹³ C NMR (100 MHz, CDC1 ₃ ) δ 149.06, 147.98 (d, J = 3.26 Hz), 130.63 (d, J = 6.65 Hz), 129.29, 123.97 (d, J = 9.34 Hz), 121.47, 120.65, 120.48 (d, J = 2.64 Hz), 62.21 (d, J = 6.71 Hz), 40.34, 33.01 (d, J = 139.1 Hz), 16.51(d, J = 5.91 Hz). HRMS (ESI) calculated [M+H] ⁺ for Ci ₈ H ₂ s0 ₃ NP: 334.1567, found: 334.1562. FTIR (cm ^"1 ): 3463, 3299, 3059, 3033, 2982, 2930, 2907, 2814, 1596, 1571, 1513, 1497, 1452, 1391, 1366, 1343, 1252 (P=0), 1190, 1 163, 1 131, 1097, 1054, 1028, 962, 870, 850, 770, 754, 700. Example 15

[0043] Synthesis of(£)-iV-MethyI-7V-phenyl-4-(2-(thiophen-2-yl) vinyl) aniline Following the general procedure, treatment of (E)- N,N-dimethyl-4-(2-(thiophen-2-yl)vinyl)aniline(0.057 g, 0.25 mmol) with 2-(trimethylsilyl)phenyl trifiuoromethanesulfonate (0.089 g, 73 μΐ, , 0.30 mmol) in the presence of KF (0.034 g, 0.60 mmol), 18-crown-6 (0.158 g, 0.60 _^ mmol) and (NFL HCOs (0.020 g, 0.25 mmol) in THF (1.0 mL) at 60 °C for 12 h ^* followed by column chromatography (Pet. ether/DCM = 90/10) afforded (E)-N- methyl-N-phenyl-4-(2-(thiophen-2-yl)vinyl)anilineas a yellow solid (0.067 g, 93%).

RJPet. ether/DCM = 80/20): 0.47; Ή NMR (400 MHz, CDC1 ₃ ) δ 7.37 (d, J = 8.6 Hz, 2H), 7.33 (t, J= 7.9 Hz, 2H ), 7.16 (d, J = 4.8 Hz, 1H), 7.13-7.10 (m, 3H), 7.06- 7.03 (m, 2H), 7.01-6.99 (m, 1H) ,6.96 (d, J = 8.6 Hz, 2H), 6.90 (d, J = 16.1 Hz, 1H ), 3.55 (s, 3H). ^,3 C NMR (100 MHz, CDC1 ₃ ) δ 148.69, 148.58, 143.62, 129.48, 129.30, 128.32, 127.66, 127.32, 125.31, 123.69, 122.61, 122.26, 119.44, 118.95, 40.36.HRMS (ESI) calculated [M+H] ⁺ for C, ₉ H _I8 NS: 292.1 154, found: 292.1184. FTIR (cm ^"1 ): 3018, 2925, 1593, 1519, 1494, 1344, 1248, 1183, 1156, 1 134, 11 14, 1085, 954, 942, 858, 826, 759, 726, 692, 583, 501.

Example 16

[0044] Synthesis ofN-Methyl-N-phenyI-4-(phenylethynyl) aniline N,N- mmol) lfonate . of KF (0.070 g, 1.20 mmol) ,18-crown-6 (0.317 g, 1.20 mmol) and (NH ₄ )HC0 ₃ (0.040 g, 0.50 mmol) in THF (2.0 mL) at 60 °C for 12 h followed by column chromatography (Pet. ether/DCM = 95/05) afforded N-methyl-N-phenyl-4-(phenylethynyl)aniline as a brown solid (0.116 g, 82%).

tf/Pet. ether/DCM = 90/10): 0.57; Ή NMR (400 MHz, CDC1 ₃ ) δ 7.52 (d, J = 7.8 , Hz, 2H), 7.41 (d, J= 8.7 Hz, 2H ), 7.38-7.30 (m, 5H), 7.17 (d, J = 7.5 Hz, 2H), 7.11 (t, J = 7.3 Hz, 1H ), 6.87 (d, J = 8.7 Hz, 2H ), 3.55 (s, 3H). ^,3 C NMR (100 MHz, CDCI ₃ ) δ 149.01, 148.33, 132.68, 131.52, 129.65, 128.41, 127.84, 124.00, 123.91, 123.76, 116.91, 113.53, 90.22, 88.11, 40.28.HRMS (ESI) calculated [M+H] ⁺ for C ₂ iH, ₈ N: 284.1434, found: 284.1470. FTIR (cm ¹ ): 3058, 3036, 2927, 2815, 221 1 (C-C triple bond), 1610, 1591, 1556, 1513, 1495, 1348, 1268, 1254, 1 192, 1130, 1115, 1081, 1069, 1026, 869, 823, 755, 691. Example 17

[0045] Synthesis oiTV-Methyl-N-phenylnaphthalen-l-amine Following the general procedure, treatment of N,N-dimethyl naphthalen-1 -amine (0.086g, 83 ί, 0.50 mmol) with 2- (trimethylsilyl)phenyltrifluoromethanesulfonate (0.179 g, 146 μί, 0.60 mmol) in the presence of KF (0.070 g, 1.20 mmol) , 18-crown-6 (0.317 g, 1.20 mmol) and (NH ₄ )HC0 ₃ (0.040 g, 0.50 mmol) in THF (2.0 mL) at 60 °C for 12 h followed by column chromatography (Pet. ether DCM = 98/02) afforded N-methyl-N-phenylnaphthalen-1 -amine as a colourless oil (0.1 15 g, 98%).

R/Pet. ether/DCM = 90/10): 0.56; Ή NMR (400 MHz, CDC1 ₃ ) δ 7.93 (t, J= 8.7 Hz, 2H), 7.83 (d, J = 8.1 Hz, 1H), 7.55-7.51 (m, 2H), 7.46 (t, J = 7.1 Hz, 1H), 7.40 (d, J = 7.3 Hz, 1H), 7.20 (t, J = 7.4 Hz, 2H), 6.77 (t, J = 7.3 Hz, 1H), 6.66 (d, J = 8.1 Hz, 2H), 3.43 (s, 3H). ¹³ C NMR (100 MHz, CDC1 ₃ ) δ 150.22, 145.48, 135.25, 131.44, 129.05, 128.58, 126.76, 126.58, 126.47, 126.35, 125.37, 123.95, 1 17.32, 1 13.64, 40.32.HRMS (ESI) calculated [M+H] ⁺ for Ci ₇ H _]6 N: 234.1277, found: 234.1293. FTIR (cm ^-1 ): 3058, 2931, 2881, 281 1, 1600, 1575, 1498, 1453, 1394, 1338, 1297, 1266, 1243, 1 187, 1 140, 1106, 1032, 1010, 885, 867, 806, 776, 750, ^' 693.

Example 18

[0046] Synthesis of 5-(Methyl (phenyl) amino) naphthalene-l-sulfonyl chloride Following the general procedure, treatment of 5- (dimethylamino) naphthalene- 1-sulfonyl chloride(0.067 g. 0.25 mmol) with 2-(trimethylsilyl)phenyl trifluoromethanesulfonate (0.149 g, 121 μί, 0.50 mmol) in the presence of KF (0.058 g, 1.0 mmol) , 18-crown-6 (0.264 g, 1.0 mmol) and (NH ₄ )HC0 ₃ (0.020 g, 0.25 mmol) in THF (2.0 mL) at 60 °C for 12 h followed by column chromatography (Pet. ether/DCM=90/10) afforded 5- (methyl(phenyl)amino)naphtha lene- 1-sulfonyl chloride as a yellow oil (0.050 g, 61 %).

R/Pet. ether DCM = 80/20): 0.30; Ή NMR (400 MHz, CDC1 ₃ ) δ 8.49 (dd, J, = 8.7 Hz, J ₂ = 2.6 Hz, 1H), 8.39-8.36 (m, 2H), 7.80 (t, J = 8.1 Hz, 1H ), 7.57-7.54 (m, 2H), 7.19 (t, J = 8.0 Hz, 2H), 6.81 (t, J = 7.3 Hz, 1H ), 6.63 (d, J = 7.9 Hz, 2H ), . 3.42 (s, 3H). ¹³ C NMR (100 MHz, CDC1 ₃ ) δ 150.01, 147.01, 132.99, 132.47, 131.63, 131.62, 130.43, 130.10, 129.30, 126.89, 124.58, 122.59, 1 18.63, 1 14.54, 40.82.HRMS calculated [M] ⁺ for C _I7 H ₁₄ C1N0 ₂ S: 331.0434, found: 331.0812. HRMS data was recorded on Synapt MALDI-MS (Waters, UK) using Synapt MALDI-MS (Waters, UK) or AB SCIEX TofTofTM 5800 using a-cyano-4- hydroxycinnamic acid as the solid matrix. FTIR (cm ¹ ): 3329, 3061, 2928, 1600, 1572, 1498, 1415, 1400 (S=0), 1341, 1261, 1223, 121 1 (S=0), 1 148, 11 10, 1044, 832, 792, 773, 748, 694, 640, 591.

Example 19

[0047] Synthesis of 4,4'-(PhenyImethylene) bis (N-methyl-N-phenylaniline

Following the general procedure, treatment of 4,4'-(phenylmethylene)bis(N ₎ N- dimethylaniline)(0.082 g, 0.25 mmol) with 2-

(trimethylsilyl)phenyl trifluoromethanesulfonate (0.179 g, 146 , 0.60 mmol) in the presence of KF (0.070 g, 1.20 mmol) ,18-crown-6 (0.317 g, 1.20 mmol) and (NH ₄ )HC0 ₃ (0.040 g, 0.50 mmol) in THF (2.0 mL) at 60 °C for 12 h followed by column chromatography (Pet. ether/DCM = 80/20) afforded 4,4'-(phenylmethylene)bis(N-methyl-N-phenylaniline) as a green oil (0.088 g, 78%).

RJPet. ether/DCM = 80/20): 0.30; Ή NMR (400 MHz, CDC1 ₃ ) 7.30-7.17 (m, 9H), 7.05-7.00 (m, 8H), 6.96-6.91 (m, 6H), 5.44 (s, 1H), 3.29 (s, 6H). ^,3 C NMR (100 MHz, CDC1 ₃ ): δ 149.13, 147.25, 144.70, 137.27, 130.20, 129.49, 129.25, 128.38, 126.27, 121.12, 120.48, 120.25, 55.72, 40.35. HRMS calculated [M+H] ⁺ for C ₃₃ H ₃₀ N ₂ : 455.2482, found: 455.1764. HRMS data was recorded on Synapt MALDI-MS (Waters, UK) using Synapt MALDI-MS (Waters, UK) or AB SCIEX TofTofTM 5800 using a-Cyano-4-hydroxycinnamic acid as the solid matrix. FTIR (cm ¹ ): 3083, 3058, 3026, 2935, 2876, 2841, 1594, 1568, 1496, 1451, 1342, 1298, 1273, 1253, 1186, 1156, 1131, 1 117, 1086, 1067, 1029, 1016, 868, 820, 797, 752, 71 1, 697.

Example 20

[0048] Synthesis of Ethyl (£)-3-(4-(methy I (phenyl) amino) phenyl) acrylate

30

Following the general procedure, treatment of ethyl (£)-3-(4-(dimethylamino)phenyl)acrylate(0.1 lOg, 0.50 mmol) with 2-(trimethylsilyl)phenyl

trifluoromethanesulfonate (0.179 g, 146 μί, 0.60 mmol) in the presence of KF (0.070 g, 1.20 mmol) , 18-crown-6 (0.317 g, 1.20 mmol) and (NFL HCOs (0.040 g, 0.50 mmol) in THF (2.0 mL) at 60 °C for 12 h followed by column chromatography (Pet. ether/EtOAc = 98/02) afforded Ethyl (E)- 3-(4-(methyl(phenyl) amino) phenyl)acrylate as a yellow oil (0.130 g, 93%). i?/Pet. ether/EtOAc = 95/05): 0.50; Ή NMR (400 MHz, CDC1 ₃ ) δ 7.63 (d, J = 16.0 Hz, 1H), 7.40-7.35 (m, 4H), 7.19-7.14 (m, 3H), 6.82 (d, J = 8.8 Hz, 2H), 6.25 (d, J = 16.0 Hz, 1H), 4.25 (q, J = 7.1 Hz, 2H), 3.35 (s, 3H), 1.33 (t, J = 7.1 Hz, 3H). ¹³ C NMR (100 MHz, CDC1 ₃ ) δ 167.83, 150.77, 147.88, 144.80, 129.77, 129.48, · 125.03, 125.84, 124.68, 1 15.79, 113.98, 60.30, 40.28, 14.50.HRMS (ESI) calculated [M+H for Ci ₈ H ₂₀ O ₂ N: 282.1489, found: 282.1484. FTIR (cm ¹ ): 3061, 3035, 2980, 2936, 2902, 1705 (ester), 1628, 1606, 1591, 1559, 1515, 1495, 1350, 1330, 1258, 1215, 1 166, 1 137, 1122, .1040, 983, 868, 821, 768, 700.

Example 21

[0049] Synthesis of (£)-iV-Methyl-4-(4-nitrostyryI)-N-phenylaniline

Following the general procedure, treatment of

(£)-N,N-dimethyl-4-(4-nitrostyryl)aniline (0.067 g, 0.25 mmol) with 2-

(trimethylsilyl)phenyl trifluoromethanesulfonate (0.090 g, 73 μί, 0.3 mmol) in the presence of KF (0.035 g, 0.6 mmol) , 18-crown-6 (0.159 g, 0.6mmol) and (NH ₄ )HC0 ₃ (0.020 g, 0.25 mmol) in THF (1.0 mL) at 60 °C for 12 h followed by column chromatography (Pet.ether/EtOAc = 92/8) afforded (£T)-N-Methyl-4-(4- nitrostyryl)-N-phenylaniline as a colourless oil (0.064 g, 78%).

tf/Pet. ether/EtOAc = 90/10): 0.56; ^! H NMR (400 MHz, CDC1 ₃ ) δ 8.10 (d, J = 8.7 ^' Hz, 2H), 7.49 (d, J = 8.8 Hz, 2H), 7.34 (d, J = 8.6 Hz, 2H), 7.28, (t, J = 7.6 Hz, 2H)7.17 (d, J = 10.7 Hz, 1H), 7.1 1-7.08 (m,2H), 7.04 (t, J = 7.4 Hz, 1H), 6.88 (d, J = 16.2Hz, 1H), 6.83 (d, J = 8.9 Hz, 2H), 3.28 (s, 3H). ^I3 C NMR (100 MHz, CDC1 ₃ ) δ 149.70, 148.28, 146.29, 144.78, 133.38, 129.68, 128.23, 127.42, 126.43, 124.29, 123.97, 123.89, 123.09, 117.21, 40.35.HRMS calculated [M+H] ⁺ for C ₂ iH, ₉ 0 ₂ N ₂ : 331.1441, found: 331.1438. FTIR (cm ¹ ): 2927, 1606, 1585, 1509 (N0 ₂ ), 1339 (N0 ₂ ), 1254, 1 188, 1 114, 971 , 837, 806, 776, 749.

Example 22

[0050] Synthesis of 5-(4-(Methyl (phenyl) amino) phenyl) thiophene-2- carbaldehyde

Following the general procedure, treatment of 5-(4- (dimethylamino)phenyl)thiophene-2- carbaldehyde(0.1 16 g, 0.50 mmol) with 2- (trimethylsilyl)phenyl trifluoromethanesulfonate

(0.179 g, 146μί , 0.60 mmol) in the presence of KF (0.070 g, 1.20 mmol) ,18- crown-6 (0.317 g, 1.20 mmol) and (NH ₄ )HC0 ₃ (0.040 g, 0.50 mmol) in THF (2.0 · mL) at 60 °C for 12 h followed by column chromatography (Pet. ether/EtOAc = 90/10) afforded 5-(4-(methyl(phenyl)amino)phenyl)thiophene-2-carbaldehyde as a green colour solid (0.079 g, 54%).

tf/Pet. ether/EtOAc = 90/10): 0.39; Ή NMR (400 MHz, CDC1 ₃ ) δ 9.86 (s, 1H), 7.71 (d, J= 3.9 Hz, 1H), 7.56 (d, J= 8.7 Hz, 2H), 7.40, (t, J= 7.7 Hz, 2H)7.29 (d, J = 3.5 Hz, 1H), 7.22-7.16 (m,3H), 6.91 (d, J = 8.8 Hz, 2H), 3.39 (s, 3H). ¹³ C NMR (100 MHz, CDC1 ₃ ) δ 182.66, 155.46, 150.21, 148.01, 140.86, 138.03, 129.79, 127.44, 124.64, 124.46, 123.65, 122.31, 1 16.58, 40.32.HRMS calculated [M+H] ⁺ for Ci ₈ H _l6 ONS: 294.0947, found: 294.0941. FTIR (cm ^"1 ): 3373, 2925, 2855, 2726, 1655 (CHO), 1590, 1458, 1377, 1231, 1081, 801, 773.

Example 23

[0051] Synthesis oCV, 3, 4-trimethyl-iV-phenyIaniline

ether/DCM = 96/4)afforded N,3,4-trimethyl-N-phenylanilineas a colourless oil (0.098 g, 93%).

/?/Pet. ether/DCM = 90/10): 0.50; Ή NMR (400 MHz, CDC1 ₃ ) δ ^' 7.30-7.26 (m, 2H), 7.13 (d, J = 8.01 Hz, 1H), 6.98-6.89 (m, 5H), 3.34 (s, 3H), 2.29 (s, 3H), 2.28 (s, 3H). ¹³ C NMR (100 MHz, CDC1 ₃ ) δ 149.51, 147.0, 137.68, 131.15, 130.55, 129.1 1, 124.31, 120.43, 1 19.64, 118.0, 40.49, 20.10, 19.21.HRMS calculated [M+H] ⁺ for Ci ₅ H, ₈ N: 212.1434, found: 212.1433. FTIR (cm ¹ ): 3022, 2920, 2809, 1595, 1496, 1450, 1343, 1300, 1 1 17, 998, 751.

Example 24

[0052] Synthesis of N-methyl-N-phenylbenzo[d][l,3]dioxol-5-amine treatment of N,N- 0.50mmol) with 6- enzo[d][l,3]dioxol-5-yl trifluoromethanesulfonate (0.205 g, 0.60 mmol) in the presence of KF (0.070 g, 1.20 mmol) , 18-crown-6 (0.317 g, 1.20 mmol) and (NH ₄ )HC0 ₃ (0.040 g, 0.50,mmol) in THF (2.0 mL) at 60 °C for 12 h followed by column chromatography (Pet. ether/DCM = 96/4) afforded N-methyl-N-phenylbenzo[d][l,3]dioxol-5-amine (0.106 g, 94%). i?/Pet. ether DCM = 90/10): 0.33; Ή NMR (400 MHz, CDC1 ₃ ) δ 7.29-7.23 (m, 2H), 6.88-6.81 (m,4H), 6.70-6.63 (m, 2H), 5.99 (s, 2H), 3.28 (s, 3H). ¹³ C NMR (100 MHz, CDC1 ₃ ) δ 149.70, 148.39, 144.12, 143.80, 129.10, 1 19.1 1, 1 17.41, 1 16.69, 108.71, 106.31 , 101.33, 40.78.HRMS calculated [M+H] ⁺ for C4H14O2N: 228.1019, found: 228.1013. FTIR (cm ¹ ): 2886, 2810, 1598, 1577, 1485, 1326, 1241 , 1214, 1 115, 1038, 939, 927, 751.

Example 25

[0053] Synthesis of 3, 4-Difluoro-N-methyI-N-PhenylaniIine

Following the general procedure, treatment of N,N- dimethylaniline (0.06 lg, 65 μΐ,, 0.50 mmol) with 4,5-difluoro- 2-(trimethylsilyl)phenyl trifluoromethanesulfonate (0.201 g,

0.60 mmol) in the presence of KF (0.070 g, 1.20 mmol) , 18- crown-6 (0.317 g, 1.20 mmol) and (NH ₄ )HC0 ₃ (0.040 g, 0.50,mmol) in THF (2.0 mL) at 60 °C for 12 h followed by column chromatography (Pet. ether/DCM = 96/4) afforded 3,4-difluoro-N-methyl-N-phenylaniline 3w as a colorless oil (0.097 g, 88%).

Λ/Pet. ether/DCM = 90/10): 0.65; Ή NMR (400 MHz, CDC1 ₃ ) δ 7.89 (t, J= 9.7 Hz, 2H), 7.57-7.52 (m,4H), 7.25-7.18 (m, 1H), 7.09-7.04 (m, lH), 2.85 (s, 3H). ¹³ C NMR (100 MHz, CDCI3) δ 170.75 (dd, Ji = 16.8 Hz, J ₂ = 307.5 Hz), 166.46, 163.69 (dd, Ji = 16.5 Hz, J ₂ = 302.0 Hz), 163.36 (dd, Ji = 2.8 Hz, J ₂ = 9.7 Hz), 142.67, 134.01, 132.17, 127.42 (d, J = 21.4 Hz), 124.4 (q, J = 3.07), 1 16.3 (d, J = 24.2 Hz), _t 31.54. HRMS calculated [M+H] ⁺ for C, ₃ Hi ₂ NF ₂ : 220.0932, found: 220.0930. FTIR ^' (cm ^"1 ): 3038, 2887, 2815, 1597, 1516, 1495, 1277 (C-F), 1 1 19, 1083, 828, 774.

Example 26

[0054] Synthesis of N,2,5-trimethyk/V-Phenylaniline

(0.067 g, 64%).

tf/Pet. ether/DCM = 90/10): 0.65; Ή NMR (400 MHz, CDC1 ₃ ) δ 7.22-7.18 (m, 3H), 7.03 (d, J = 7.69 Hz, 1H), 6.99 (s, 1 H), 6 3 (t, J = 7.22 Hz, 1H), 6.73 (d, J = 7.91 Hz, 2H), 3.23 (s, 3H) 2.33 (s, 3H), 2.12 (s, 3H). ¹³ C NMR (100 MHz, CDCI ₃ ) δ 149.31, 146.7, 137.32, 133.60, 131.24, 129.07, 128.93, 127.32, 127.32, 1 16.74, 1 12.88, 39.13, 20.99, 17.52.HRMS calculated [M+H] ⁺ for Ct ₅ Hi ₈ N: 212.1434, found: 212.1432. FTIR (cm ¹ ): 3088, 3024, 2921, 2809, 1575, 1499, 1450, 1340, ^' 1 1 15, 1066, 815, 748.

Example 27

[0055] Synthesis of 3-Methoxy-N-methyl-N-Phenylaniljne

Following the general procedure, treatment of N,N- dimethylaniline (0.061 g, 65 μί, 0.50 mmol) with 2-methoxy-6- (trimethylsilyl)phenyl trifluoromethanesulfonate (0.197 g, 0.60 mmol) in the presence of KF (0.070 g, 1.20 mmol) , 18-crown-6 ol) and (NFL HCO3 (0.040 g, 0.50 mmol) in THF (2.0 mL) at 60 °C for 12 h followed by column chromatography (Pet. ether/DCM = 96/4) afforded 3-Methoxy-N-methyl-N-phenylaniline as a colorless oil (0.087 g, 95%).

Λ/Pet. ether DCM = 90/10): 0.33; Ή NMR (400 MHz, CDC1 ₃ ) δ 7.32 (t, J = 8.1 Hz, 2H), 7.19 (d, J= 7.9 Hz, 1H), 7.10 (d, J = 7.9 Hz, 2H), 7.02, (t, J= 7.5 Hz, 1H), 6.62 (d, J = 8.3 Hz, 1H), 6.58 (s, 1H) 6.52(d, J = 7.9 Ηζ, ΙΗ), 3.79 (s, 3H), 3.34 (s, 3H). ¹³ C NMR (100 MHz, CDC1 ₃ ) δ 160.67, 150.50, 148.98, 129.88, 129.36, 122.1 1, 121.72, 1 12.33, 106.04, 105.72, 55.30, 40.42.HRMS calculated [M+H] ⁺ for CwHieON: 214.1226, found: 214.1229. FTIR (cm ^" '): 2999, 2936, 2834, 1595, 1494, 1437, 1436, 1347, 1 169, 1 127, 1049, 991, 754.

Example 28

[0056] Synthesis of N-Methyl-N-PhenyInaphthalen-2-amine

Following the general procedure, treatment of N,N- dimethylaniline (0.06 lg, 65 L, 0.50 mmol) with 2- (trimethylsilyl)naphthalen- 1 -yl trifluoromethanesulfonate (0.209 g, 0.60 mmol) in the presence of KF (0.070 g, 1.20 mmol), 18-crown-6 (0.317 g, 1.20 mmol) and (NH HCOs (0.040 g, 0.50,mmol) in THF (2.0 mL) at 60 °C for 12 h followed by column chromatography (Pet. ether/DCM = 96/4) afforded N-methyl-N-phenylnaphthalen-2 -amine as a colorless oil (0.1 12 g, 96%).

R/Pet. ether/DCM = 90/10): 0.48; Ή NMR (400 MHz, CDC1 ₃ ) δ 7.79 (d, J = 8.18 Hz, lH), 7.74 (t, J = 7.7 Hz, 2H), 7.48-7.45 (m, 1Η),7.39-7.34 (m, 4H), 7.29-7.25 (m, 1H), 7.16 (d, J = 7.74, 2H), 7.07 (t, J = 7.25, 1H), 3.47 (s, 3H). ¹³ C NMR (100 MHz, CDCI3) δ 149.16, 146.68, 134.80, 129.42, 129.26, 128.71, 127.67, 126.87, 126.40, 123.87, 122.13.121.92, 121.53, 1 14.74, 40.78.HRMS calculated [M+H] ⁺ for · CnHigN: 234.1277, found: 234.1274. FTIR (cm ^"1 ): 3056, 2940, 281 1, 1628, 1593, 1494, 1364, 1297, 1281, 1321, 1 1 19, 813, 747, 699. Example 29

[0057] Synthesis of iV,4-dimethyl-N-phenylaniIine and N,3-dimethyl-N- phenylaniline Following the general procedure, treatment of N,N-dimethylaniline (0.061 g, 65 μί, 0.50 mmol) with 4-methyl-2-

(trimethylsilyl)phenyl trifluoromethanesulfonate(0.187 g, 0.60 mmol) in the presence of KF (0.070 g, 1.20 mmol), 18-crown-6 (0.317 g, 1.20 mmol) and (NH ₄ )HC0 ₃ (0.040 g, 0.50,mmol) in THF (2.0 mL) at 60 °C for 12 h followed by column chromatography (Pet ether/DCM =96/4) afforded N,4-dimethyl-N-phenylaniline and N,3-dimethyl-N- phenylaniline as a mixture of regioisomers in 1.3: 1 ratio as a colorless oil (0.092 g, 93%).

R/Pet ether/DCM =90/10): 0.55; Ή NMR (400 MHz, CDC1 ₃ ) of Major isomer; δ 7.35-7.31 (m, 2H), 7.24 (t, J = 7.6Hz, 1H), 7.09-7.08 (m, 2H), 6.96-6.91 (m, 3H), 6.87 (d, J = 7.2Hz, 1H), 3.37 (s, 3H), 2.37 (s, 3H). ¹³ C NMR (100 MHz, CDC1 ₃ ) of Major isomer; δ 149.23, 149.12, 139.14, 129.15, 122.69, 121.57, 120.22, 118.28, 40.40, 21.70. Ή NMR (400 MHz, CDC1 ₃ ) of Minor isomer; δ 7.30-7.28 (m, 2H), 7.18 (d, J = 8.20Hz, 2H), 7.07-7.06 (m, 2H), 7.03-6.99 (m, 3H), 3.35 (s, 3H), 2.39 (s, 3H). ¹³ C NMR (100 MHz, CDC1 ₃ ) of Minor isomer; δ 149.45, 146.68, 132.19, 130.04, 129.26, 122.49, 121.06, 1 19.91, 118.04, 40.46, 20.88.HRMS calculated [M+H] ⁺ for Ci ₄ H _]6 N: 198.1277, found: 198.1275. FTIR (cm ^"1 ): 3026, 2920, 2874, 2810, 1595, 1509, 1342, 1260, 1129, 1090, 1028, 992.

Example 30

[0058] Synthesis of N-Methyl-N-(p-tolyl) benzo[d][l,3]dioxoI-5-amine

To a flame-dried round bottom flask equipped with a magnetic stir bar were added N,N dimethyl-N-(p-tolyl)benzo[d] · [l,3]dioxol-4-aminium salt (6.HOTf) (0.102 g, 0.25 mmol), 18- crown-6 (0.158 g, 0.60 mmol), KF (0.035 g, 0.60 mmol) and (NH ₄ )HC0 ₃ (0.020 g, 0.25 mmol) at room temperature (27°C).Then the mixture was dissolved in THF (1.0 mL) under argon atmosphere and round bottom flask kept in a pre-heated oil bath at 60 °C for 12 h. The reaction mixture cooled and the residue on column chromatography (Pet. ether/DCM = 90/10) afforded N-methyl-N- ?-tolyl) benzo[d][l, 3] dioxol-5-amine as a colorless oil (0.043 g, 70%).

R _j (Pet. ether/DCM = 80/20): 0.32; Ή NMR (400 MHz, CDC1 ₃ ) δ 7.07 (d, J = 8.3 Hz, 2H ), 6.83 (d, J= 8.3 Hz, 2H ), 6.76 (d, J= 8.3 Hz, 1H ), 6.62 (d, J= 2.1 Hz, 1H ), 6.53 (dd, J, = 8.3 Hz, J ₂ = 2.1 Hz, 1H), 5.94 (s, 2H), 3.23 (s, 3H), 2.30 (s, 3H). ¹³ C NMR (100 MHz, CDC1 ₃ ) δ 148.30, 147.52, 144.58, 143.17, 129.76, 129.58, 1 18.67, 1 15.21, 108.56, 104.65, 101.17, 40.99, 20.63.HRMS (ESI) calculated [M+H] ⁺ for Ci ₅ Hi ₆ 0 ₂ N: 242.1 176, found: 242.1162. FTIR (cm ^-1 ): 2920, 2883, 2808, 1611, 1514, 1504, 1485, 1324, 1284, 1241, 1214, 1 155, 1 1 13, 1039, 940, 927, 841, 81 1, 781, 726.

Example 31

[0059] Synthesis of N, 2, 5-TrimethyWV-phenylaniIine-6-d

Following the general procedure, treatment of N.N-dimethylaniline (0.030 g, 32 μί, 0.25 mmol) with 3,6-dimethyl-2- (trimethylsilyl)phenyl trifluoromethanesulfonate(0.098 g, 0.30 mmol) in the presence of KF (0.035 g, 0.60 mmol), 18-crown-6 (0.158 g, 0.60 mmol) and D ₂ 0 (0.005 g, 4.6 μί, 0.25 mmol) in THF (1.0 mL) at 60 °C for 12 h followed by column chromatography (Pet. ether EtOAc = 99/01) afforded N,2,5-trimethyl-N-phenylaniline-6-d as a colorless oil (0.036 g, 69%).

R Pet. ether DCM = 90/10): 0.65; 1H NMR (400 MHz, CDC1 ₃ ) δ 7.22-7.18 (m, 3H), 7.04 (d, J = 7.7 Hz, 1H), 7.00 (s, 32% H), 6.73 (t, J = 7.9 Hz, 1H), 6.57 (d, J = 7.9 Hz, 2H), 3.24 (s, 3H) 2.33 (s, 3H), 2.13 (s, 3H). ¹³ C NMR (100 MHz, CDC1 ₃ ) δ 149.34, 146.73, 146.67, 137.32, 137.23, 133.60, 133.58, 131.24, 129.07, 128.92, 127.32, 1 16.77, 1 12.92, 39.15, 20.91, 17.51.HRMS(ESI) calculated [M+H] ⁺ for C, ₅ Hi ₇ ² HN: 213.1497, found: 213.1490.

Example 32

[0060] Synthesis of 3-(Methyl(phenyl)amino)phenol, 3-Methoxy-N-methyI-N- phenylaniline and N-MethyI-3-phenoxy-N-phenylaniIine

Following the general procedure, treatment of 3-(dimethylamino)phenol (0.069 g, 0.50 mmol) with 2-(trimethylsilyl)phenyl trifluoromethanesulfonate (0.179 g, 146 μΐ. , 0.60 mmol) in the presence of KF (0.070 g, 1.20 mmol) , 18-crown-6 (0.317 g, 1.20 mmol) and (NH ₄ )HC0 ₃ (0.040 g, 0.50 mmol) in THF (2.0 mL) at 60 °C for 12 h followed by column chromatography afforded three product as follows, 3- (methyl(phenyl)amino)phenol as a brown oil (0.030 g, 30%), 3-methoxy-N-methyl- N-phenylaniline as a colorless oil (0.057 g, 53%), and N-methyl-3-phenoxy-N- phenylanilineas a colorless oil (0.020 g, 14%).

' 3060, 3037, 2929, 2814, 1591, 1496, 1459, 1349, 1275, 1 195, 1 165, 1126, 1092, 1027, 992, 955, 943, 829, 758, 693.

3-Methoxy-N-methyl-N-phenylaniline

3-(dimethylamino)phenol on reaction with 2-(trimethylsilyl)phenyl trifluoromethanesulfonate resulted in the formation of 3- (methyl(phenyl)amino)phenol, in situ, the free phenolic group is methylated or arylated to furnishe the 3-methoxy-N-methyl-N-phenylaniline (Example No. 27) and N-methyl-3-phenoxy-N-phenylaniline (Example No. 28) respectively. '

148.98, 129.89, 129.36, 122.1 1, 121.73, 112.33, 106.04, 105.71, 55.30, 40.42.HRMS (ESI) calculated [M+H] ⁺ for C,4H, ₆ ON: 214.1226, found: 214.1226. FTIR (cm ^" '): 2999, 2932, 2834, 1592, 1493, 1467, 1347, 1274, 1215, 1 169, 1 127, 1094, 1048, 929, 754.

N-Methyl-3-phenoxy-iV-phenyIaniIine

Vfo R/Pet. ether/DCM = 90/10): 0.50; 1H NMR (400 MHz, CDC1 ₃ ) δ N*Ph 7.34-7.30 (m, 4H), 7.17 (t, J = 8.1 Hz, 1H), 7.12 (d, J = 7.8 Hz, 2H), 7.08 (t, J = 7.4 Hz, 1H), 7.05-7.02 (m, 3H), 6.69 (dd, J, = 8.2 Hz, J ₂ = 1.5 Hz, 1H), 6.67 (t, J= 2.0 Hz, 1H), 6.51 (dd, J, = 8.2, J ₂ =1.5 Hz,

1H), 3.30 (s, 3H). ^{I 3} C NMR (100 MHz, CDC1 ₃ ) δ 158.12, 157.44, 150.75, 148.70, 130.03, 129.77, 129.49, 123.15, 122.87, 122.68, 1 18.84, 1 13.63, 1 10.50, 109.33, 40.41.HRMS (ESI) calculated [M+H] ⁺ for C, ₉ H, ₈ ON: 276.1383, found: 276.1385. FTIR (cm ^"1 ): 3063, 3038, 2925, 2814, 1588, 1488, 1347, 1260, ^' 1222, 1 163, 1 125, 1092, 1072, 1024, 993, 959, 847, 769, 754, 691. Example 33

[0061] Synthesis of /V-Ethyl-N-phenylaniline

Following the general procedure, treatment of N,N- diethylaniline(0.075g, 81 μΐ,, 0.50 mmol) with 2- (trimethylsilyl)phenyl trifluoromethanesulfonate(0.179 g, 146 μί, 0.60 mmol) in the presence of KF (0.070 g, 1.20 mmol) , 18-crown-6 (0.317 g, 1.20 mmol) in THF (2.0 mL) at 60 °C for 12 h followed by column chromatography (Pet. ether/DCM = 98/02) afforded N-Ethyl-N-phenylaniline as a colorless oil (0.060 g, 61%).

R/Pet. ether DCM = 90/10): 0.66; 1H NMR (400 MHz, CDC1 ₃ ) δ 7.28-7.25 (m, 4H), 7.00 (d, J= 7.5 Hz, 4H), 6.94 (t, J = 7.4 Hz, 2H), 3.80-3.76 (m, 2H), 1.24-1.21 (m, 3H). ¹³ C NMR (100 MHz, CDC1 ₃ ) δ 147.89, 129.38, 121.22, 121.06, 46.54, 12.82.HRMS (ESI) calculated [M+H] ⁺ for Ci ₄ Hi ₆ N: 198.1277, found: 198.1277. FTIR (cm ^-1 ): 3060, 3036, 2972, 2929, 2870, 1588, 1495, 1371, 1348, 1261, 1241, 1 131, 1 100, 783, 748, 693.

Example 34

[0062] Synthesis of N-Phenyl-iV-(2-vinylbenzyl)aniline

Treatment of l,2,3,4-tetrahydroisoquinoline(0.033 g, 32 μΐ,, 0.25 mmol) with 2-(trimethylsilyl)phenyl trifluoromethanesulfonate (0.179 g, 146 μΐ, , 0.60 mmol) in the presence of KF (0.070 g, 1.20 mmol) and 18-crown-6 (0.317 g, 1.20 mmol) in THF (2.0 mL) at 60 °C for 12 h followed by column chromatography (Pet. ether/DCM=98/02) afforded N-phenyl-N- (2-vinylbenzyl)aniline as a white solid (0.060 g, 86%).

7?/Pet. ether/DCM = 90/10): 0.65; Ή NMR (400 MHz, CDC1 ₃ ) δ 7.50 (d, J = 7.0 Hz, 1H), 7.42 (d, J = 7.0 Hz, 1H ), 7.27-7.18 (m, 6H), 7.07 (d, J = 7.9 Hz, 4H), 7.02-6.94 (m, 3H), 5.68 (d, J = 17.3 Hz, 1H ), 5.37 (d, J = 1 1.0 Hz, 1H ), 5.04 (s, 2H). ^{, 3} C NMR (100 MHz, CDC1 ₃ ) δ 148.06, 136.10, 135.49, 133.76, 129.40, 128.07, 127.08, 126.85, 126.23, 121.59, 120.77, 1 16.66, 54.37.HRMS (ESI) calculated [M+H] ⁺ for C ₂ iH ₂₀ N: 286.1595, found: 286.1592.FTIR (cm ^_l ):3061, 3028, 2921, 2853, 1579, 1485, 1338, 1227, 1062, 986, 914, 848.

ADVANTAGES OF THE INVENTION

1. Transition-Metal free approach.

2. High yields.

3. Use of Simple and easily available starting materials.

4. Synthesis of Arylamines which play a key role in a number of fields like Pharmaceuticals, Agrochemicals, Dyes, Electronic materials.